Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Four and A Half LIM Domains 3 (FHL3) Peptide

FHL3 Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN939223
382,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 20 à 27 jours ouvrables

Aperçu rapide pour Four and A Half LIM Domains 3 (FHL3) Peptide (ABIN939223)

Antigène

FHL3 (Four and A Half LIM Domains 3 (FHL3))

Origine

Mammifères

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Type de proteíne

    Synthetic

    Séquence

    HRECLVCTGC QTPLAGQQFT SRDEDPYCVA CFGELFAPKC SSCKRPIVGL

    Attributs du produit

    A synthetic peptide for use as a blocking control in assays to test for specificity of FHL3 antibody,
    Alternative Names: FHL3 control peptide, FHL3 antibody Blocking Peptide, Anti-FHL3 Blocking Peptide, four and a half LIM domains 3 Blocking Peptide, MGC19547 Blocking Peptide, MGC23614 Blocking Peptide, MGC8696 Blocking Peptide, SLIM2 Blocking Peptide, FHL3, FHL-3, FHL 3, FHL-3 Blocking Peptide, FHL 3 Blocking Peptide
  • Indications d'application

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C long term.
  • Antigène

    FHL3 (Four and A Half LIM Domains 3 (FHL3))

    Sujet

    FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.

    Poids moléculaire

    31 kDa
Vous êtes ici:
Chat with us!